Covid causing diabetes

Diabetes morbidity, India, 77 million, China, 116 million, UK, 3.9million, US 34 millionUploaded 12-08-21In case you want to support Our community outreach through donationsUSE SENDWAVE/ WorldRemit /Western UnionMobile money number:+256785698803Country: UgandaRegistered name : Wefwafwa AndrewEmail me when you send: wefandrew@gmail.comAddresses: Republic streetCity: Mbale cityCountry: UgandaUK 3.9 to 4.7 million, + 700 new cases per dayhttps://www.diabetes.org.uk/about_us/news/new-stats-people-living-with-diabetesUS, 34.2 millionhttps://www.cdc.gov/diabetes/library/features/diabetes-stat-report.htmlRhino-orbital mucormycosis following COVID-19 in previously non-diabetic, immunocompetent patientshttps://www.tandfonline.com/doi/abs/10.1080/01676830.2021.1960382?journalCode=iorb20India, more than 45,000 cases of MucormycosisAffects nose, eyes and sometimes the brainUsual onset, 12-18 days after recovery from Covid-1913 of 127 patients had new onset diabetesAverage age, 36 yearsSeven of 13, not given steroids or supplemental oxygenCovid-19: Fears over sharp rise in diabetes in Indiahttps://www.bbc.co.uk/news/world-asia-india-58066767https://www.sciencedirect.com/journal/diabetes-and-metabolic-syndrome-clinical-research-and-reviewsDr Anoop MisraOur assessment is that such patients were probably predisposed to diabetes because of obesity and family historySevere diabetes caused by pancreatic damage, less commonProportion of newly diagnosed diabetes in COVID-19 patients: A systematic review and meta-analysishttps://dom-pubs.onlinelibrary.wiley.com/doi/10.1111/dom.14269https://www.washingtonpost.com/health/2021/02/01/covid-new-onset-diabetes/Meta-analysis, 8 studies, n = 3,700 patients14.4% for newly diagnosed diabetes in hospitalized COVID-19 patientsnewly diagnosed diabetes may confer a greater risk for poor prognosisWe are now seeing a classic example of a lethal intersection between a communicable and a non-communicable disease.PhysiologyStress response associated with severe illnessTreatment with glucocorticoidsDiabetogenic effect of COVID-19 should also be consideredHigh degree of insulin resistanceHigh insulin requirements in severely or critically ill COVID-19 patients with diabetesMore diabetic ketoacidosis and hyperosmolar hyperglycaemic in COVID-19 patients with diabetesSARS-CoV-2), attaching to ACE2 receptors in beta cellsMay also injure beta cells by pro-inflammatory cytokines (e.g. interleukin-6)Enhancing autoimmunity in genetically predisposed peopleACE2 receptors are expressed in the liver, adipose tissue and skeletal muscleMay impair responses to insulinExploring research: can coronavirus cause diabetes, or make it worse?https://www.diabetes.org.uk/about_us/news/new-worse-cases-coronavirus#:~:text=Small%20studies%20looking%20at%20pancreas,can't%20produce%20enough%20insulin.https://care.diabetesjournals.org/content/early/2020/08/13/dc20-155147,000 people in England, admitted to hospital for coronavirus before August 2020Seven months after discharged5% of people went on to develop diabetesHospitalised patients, 1.5 times more likely to be diagnosed with diabetes after dischargeMatched with non- hospitalised people of the same age and backgroundLets find outhttp://covidiab.e-dendrite.com Post-covid syndrome in individuals admitted to hospital with covid-19: retrospective cohort studyhttps://pubmed.ncbi.nlm.nih.gov/33789877/Follow-up of 140 days, 47,780 admissions14,060 of readmitted (x4)5,875 died after discharge (x8)Also increasedRespiratory disease (P 0.001)Diabetes (P 0.001)Cardiovascular disease (P 0.001)Increased rates of multiorgan dysfunction Learn more about your ad choices. Visit megaphone.fm/adchoices Learn more about your ad choices. Visit megaphone.fm/adchoices